Latest Dendreon Stories
Ex-Vivo Manipulation of Autologous Hematopoietic Stem Cells Complements Dendritic Cell-based Vaccine Platform; Potential to Develop Single-Agent and Combination Immunotherapeutics LOS
-Conference Call and Webcast on September 12, 2014 at 8:30 a.m. ET, 5:30 a.m. PT- MENLO PARK, Calif. and LONDON, Sept.
Eighty-four percent of shareholder votes cast support annual election of board members. DETROIT, June 5, 2014 /PRNewswire/ -- Eighty-four percent (84%) of votes cast by shareholders
LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Leading Cancer Immunotherapy Startup also Bolsters Leadership Team with Two Key Appointments SEATTLE, April 24, 2014 /PRNewswire-USNewswire/ -- Juno Therapeutics, a biotechnology
MARINA DEL REY, Calif., April 23, 2014 /PRNewswire/ -- Join Prostate Oncology Specialists for an educational talk about PROVENGE - a treatment to stimulate the immune system for advanced prostate
- Easily ashamed, having a strong sense of shame; modest; chaste.
- Of or pertaining to the external organs of generation.